exp7711 has been researched along with l 158809 in 4 studies
| Studies (exp7711) | Trials (exp7711) | Recent Studies (post-2010) (exp7711) | Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) |
|---|---|---|---|---|---|
| 18 | 0 | 1 | 137 | 0 | 7 |
| Protein | Taxonomy | exp7711 (IC50) | l 158809 (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0015 | |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.0003 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0002 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashton, WT; Cantone, CL; Chang, LL; Chang, RS; Chen, TB; Faust, KA; Hutchins, SM; Lotti, VJ; MacCoss, M; Strelitz, RA | 1 |
| Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR | 1 |
| Berellini, G; Cruciani, G; Mannhold, R | 1 |
| Meanwell, NA | 1 |
1 review(s) available for exp7711 and l 158809
| Article | Year |
|---|---|
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship | 1996 |
3 other study(ies) available for exp7711 and l 158809
| Article | Year |
|---|---|
Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Blood Pressure; Male; Molecular Structure; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Triazoles | 1993 |
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles | 2005 |
Synopsis of some recent tactical application of bioisosteres in drug design.
Topics: Cytochrome P-450 Enzyme System; Drug Design | 2011 |